Cargando…

Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics

In order to assess the significance of drug/substance levels measured in intensive care medicine and clinical and forensic toxicology as well as for therapeutic drug monitoring, it is essential that a comprehensive collection of data is readily available. We revisited and expanded our 2012 compilati...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulz, Martin, Schmoldt, Achim, Andresen-Streichert, Hilke, Iwersen-Bergmann, Stefanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201985/
https://www.ncbi.nlm.nih.gov/pubmed/32375836
http://dx.doi.org/10.1186/s13054-020-02915-5
_version_ 1783529648566566912
author Schulz, Martin
Schmoldt, Achim
Andresen-Streichert, Hilke
Iwersen-Bergmann, Stefanie
author_facet Schulz, Martin
Schmoldt, Achim
Andresen-Streichert, Hilke
Iwersen-Bergmann, Stefanie
author_sort Schulz, Martin
collection PubMed
description In order to assess the significance of drug/substance levels measured in intensive care medicine and clinical and forensic toxicology as well as for therapeutic drug monitoring, it is essential that a comprehensive collection of data is readily available. We revisited and expanded our 2012 compilation of therapeutic and toxic plasma concentration ranges as well as half-lives of now more than 1100 drugs and other xenobiotics. Data have been abstracted from original papers, text books, and previous compilations and have been completed with data collected in our own forensic and clinical toxicology laboratories. We compiled the data presented in the table and the corresponding annotations over the past 30+ years. A previous compilation was completely double-checked, revised, and updated, if necessary. In addition, more than 200 substances, especially drugs who have been introduced since 2012 to the market as well as illegal drugs and other xenobiotics which became known to cause intoxications were added. We carefully referenced all data. Moreover, the annotations providing details were updated and revised, when necessary. For more than 1100 drugs and other xenobiotics, therapeutic (“normal”) and, if data was available, toxic, and comatose-fatal plasma/blood concentrations as well as elimination half-lives were compiled in a table. In case of intoxications, the blood concentration of the substance and/or metabolite better predicts the clinical severity of the case when compared to the assumed amount and time of ingestion. Comparing and contrasting the clinical case against the data provided, including the half-life, may support the decision for or against further intensive care. In addition, the data provided are useful for the therapeutic monitoring of pharmacotherapies, to facilitate the diagnostic assessment and monitoring of acute and chronic intoxications as well as to support forensic and clinical expert opinions.
format Online
Article
Text
id pubmed-7201985
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72019852020-05-09 Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics Schulz, Martin Schmoldt, Achim Andresen-Streichert, Hilke Iwersen-Bergmann, Stefanie Crit Care Review In order to assess the significance of drug/substance levels measured in intensive care medicine and clinical and forensic toxicology as well as for therapeutic drug monitoring, it is essential that a comprehensive collection of data is readily available. We revisited and expanded our 2012 compilation of therapeutic and toxic plasma concentration ranges as well as half-lives of now more than 1100 drugs and other xenobiotics. Data have been abstracted from original papers, text books, and previous compilations and have been completed with data collected in our own forensic and clinical toxicology laboratories. We compiled the data presented in the table and the corresponding annotations over the past 30+ years. A previous compilation was completely double-checked, revised, and updated, if necessary. In addition, more than 200 substances, especially drugs who have been introduced since 2012 to the market as well as illegal drugs and other xenobiotics which became known to cause intoxications were added. We carefully referenced all data. Moreover, the annotations providing details were updated and revised, when necessary. For more than 1100 drugs and other xenobiotics, therapeutic (“normal”) and, if data was available, toxic, and comatose-fatal plasma/blood concentrations as well as elimination half-lives were compiled in a table. In case of intoxications, the blood concentration of the substance and/or metabolite better predicts the clinical severity of the case when compared to the assumed amount and time of ingestion. Comparing and contrasting the clinical case against the data provided, including the half-life, may support the decision for or against further intensive care. In addition, the data provided are useful for the therapeutic monitoring of pharmacotherapies, to facilitate the diagnostic assessment and monitoring of acute and chronic intoxications as well as to support forensic and clinical expert opinions. BioMed Central 2020-05-06 /pmc/articles/PMC7201985/ /pubmed/32375836 http://dx.doi.org/10.1186/s13054-020-02915-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Schulz, Martin
Schmoldt, Achim
Andresen-Streichert, Hilke
Iwersen-Bergmann, Stefanie
Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics
title Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics
title_full Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics
title_fullStr Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics
title_full_unstemmed Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics
title_short Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics
title_sort revisited: therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201985/
https://www.ncbi.nlm.nih.gov/pubmed/32375836
http://dx.doi.org/10.1186/s13054-020-02915-5
work_keys_str_mv AT schulzmartin revisitedtherapeuticandtoxicbloodconcentrationsofmorethan1100drugsandotherxenobiotics
AT schmoldtachim revisitedtherapeuticandtoxicbloodconcentrationsofmorethan1100drugsandotherxenobiotics
AT andresenstreicherthilke revisitedtherapeuticandtoxicbloodconcentrationsofmorethan1100drugsandotherxenobiotics
AT iwersenbergmannstefanie revisitedtherapeuticandtoxicbloodconcentrationsofmorethan1100drugsandotherxenobiotics